Patents by Inventor Yuan-Ling Ku

Yuan-Ling Ku has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of aster extract in the treatment of opioid-induced constipation
    Patent number: 9144590
    Abstract: Disclosed herein is the use of an extract from an Aster species for the preparation of a medicament for the treatment of opioid-induced constipation. The extract is extracted from fresh and/or dried roots and rhizomes of a Tatarian aster (Aster tartaricus) plant, in which the extraction uses water or 40-95% (v/v) ethanol as an extractant to obtain an extraction mixture. In some embodiments, the extraction mixture is then eluted with water followed by at least one eluent.
    Type: Grant
    Filed: December 23, 2011
    Date of Patent: September 29, 2015
    Assignee: Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Jui-Ching Chen, Che-Yi Lin, Chien-Chang Wu, Cheng-Po Huang, Yuan-Ling Ku, Yueh-Chu Chen, Yu-Hsuan Lin, Chih-Sheng Hung
  • Antitussive composition and method for making the same
    Patent number: 8257759
    Abstract: An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the Morus australis Poir extract as an active component. The effective Morus australis Poir extract is prepared by extracting the root-bark of the Morus australis Poir with water, ethanol, acetone, ethyl acetate, or a combination thereof. The crude extract can be further fractioned by ultrafiltration or reverse phase column.
    Type: Grant
    Filed: December 25, 2008
    Date of Patent: September 4, 2012
    Assignee: Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Yuan-Ling Ku, Chien-Jen Shih, Hsiao-Chu Huang, Chun-Hung Kuo, Yi-Chen Lin, Yueh-Chu Chen, Feng-Nien Ko
  • USE OF ASTER EXTRACT IN THE TREATMENT OF OPIOID-INDUCED CONSTIPATION
    Publication number: 20120164251
    Abstract: Disclosed herein is the use of an extract from an Aster species for the preparation of a medicament for the treatment of opioid-induced constipation. The extract is extracted from fresh and/or dried roots and rhizomes of a Tatarian aster (Aster tartaricus) plant, in which the extraction uses water or 40-95% (v/v) ethanol as an extractant to obtain an extraction mixture. In some embodiments, the extraction mixture is then eluted with water followed by at least one eluent.
    Type: Application
    Filed: December 23, 2011
    Publication date: June 28, 2012
    Inventors: Jui-Ching CHEN, Che-Yi Lin, Chien-Chang Wu, Cheng-Po Huang, Yuan-Ling Ku, Yueh-Chu Chen, Yu-Hsuan Lin, Chih-Sheng Hung
  • Anti-bacterial use of extract from poir. and compound kuwanon h
    Patent number: 8071142
    Abstract: An extract prepared from the root barks of Morus australis Poir.
    Type: Grant
    Filed: December 29, 2008
    Date of Patent: December 6, 2011
    Assignee: Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Yuan-Ling Ku, Shih-Tsun Liang, Yu-Hsuan Lin, Liang-Hua Chen, Ying-Yu Kuo, Feng-Nien Ko
  • USES OF 2-[PIPERIDINYL] METHYL-2, 3-DIHYDROIMIDAZO [1,2-C] QUINAZOLIN-5 (6H)-ONE FOR PROVIDING AN ANALGESIC EFFECT, ANTI-ALLERGIC EFFECT AND HISTAMINE H1 RECEPTOR ANTAGONISM EFFECT
    Publication number: 20100292257
    Abstract: The present invention discloses new uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect in a patient, treating passive cutaneous anaphylaxis in a patient, and in eliciting a histamine H1 receptor antagonism effect in a patient to treat a disease or disorder, such as allergy.
    Type: Application
    Filed: July 26, 2010
    Publication date: November 18, 2010
    Applicant: Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Feng-Nien KO, Yuan-Ling Ku
  • ANTITUSSIVE COMPOSITION AND METHOD FOR MAKING THE SAME
    Publication number: 20100166890
    Abstract: An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the Morus australis Poir extract as an active component. The effective Morus australis Poir extract is prepared by extracting the root-bark of the Morus australis Poir with water, ethanol, acetone, ethyl acetate, or a combination thereof. The crude extract can be further fractioned by ultrafiltration or reverse phase column.
    Type: Application
    Filed: December 25, 2008
    Publication date: July 1, 2010
    Applicant: Pharmaceutical Industry Technology and Development Center
    Inventors: Yuan-Ling Ku, Chien-Jen Shih, Hsiao-Chu Huang, Chun-Hung Kuo, Yi-Chen Lin, Yueh-Chu Chen
  • ANTI-BACTERIAL USE OF EXTRACT FROM MORUS AUSTRALIS POIR. AND COMPOUND KUWANON H
    Publication number: 20100166898
    Abstract: An extract prepared from the root barks of Morus australis Poir.
    Type: Application
    Filed: December 29, 2008
    Publication date: July 1, 2010
    Applicant: Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Yuan-Ling Ku, Shih-Tsun Liang, Yu-Hsuan Lin, Liang-Hua Chen, Ying-Yu Kuo
  • Uses of 2-[piperidinyl]methyl-2, 3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an analgesic effect, anti-allergic effect and histamine H1 receptor antagonism effect
    Publication number: 20090082373
    Abstract: The present invention discloses new uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect in a patient, treating passive cutaneous anaphylaxis in a patient, and in eliciting a histamine H1 receptor antagonism effect in a patient to treat a disease or disorder, such as allergy.
    Type: Application
    Filed: October 18, 2007
    Publication date: March 26, 2009
    Applicant: Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Feng-Nien Ko, Yuan-Ling Ku